More from CROI: DoxyPEP, Long-Acting ART
The latest and perhaps final summary of HIV.gov insights from CROI 2024 focuses on Doxy-PEP (prevention of STIs) and long-acting antiretroviral therapies.
News Article updated on 03/14/2024